Showing 1 to 10 of 14
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| Metreleptin for treating lipodystrophy | Reference number:HST14 | HST00014 | Published:24 February 2021 | 20210224 | Last updated:24 February 2021 | 20210224 |
| Volanesorsen for treating familial chylomicronaemia syndrome | Reference number:HST13 | HST00013 | Published:21 October 2020 | 20201021 | Last updated:21 October 2020 | 20201021 |
| Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 | Reference number:HST12 | HST00012 | Published:27 November 2019 | 20191127 | Last updated:27 November 2019 | 20191127 |
| Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations | Reference number:HST11 | HST00011 | Published:09 October 2019 | 20191009 | Last updated:09 October 2019 | 20191009 |
| Patisiran for treating hereditary transthyretin amyloidosis | Reference number:HST10 | HST00010 | Published:14 August 2019 | 20190814 | Last updated:14 August 2019 | 20190814 |
| Inotersen for treating hereditary transthyretin amyloidosis | Reference number:HST9 | HST00009 | Published:22 May 2019 | 20190522 | Last updated:22 May 2019 | 20190522 |
| Burosumab for treating X-linked hypophosphataemia in children and young people | Reference number:HST8 | HST00008 | Published:10 October 2018 | 20181010 | Last updated:10 October 2018 | 20181010 |
| Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency | Reference number:HST7 | HST00007 | Published:07 February 2018 | 20180207 | Last updated:07 February 2018 | 20180207 |
| Asfotase alfa for treating paediatric-onset hypophosphatasia | Reference number:HST6 | HST00006 | Published:02 August 2017 | 20170802 | Last updated:02 August 2017 | 20170802 |
| Eliglustat for treating type 1 Gaucher disease | Reference number:HST5 | HST00005 | Published:28 June 2017 | 20170628 | Last updated:28 June 2017 | 20170628 |